1. Home
  2. Analysis
  3. Clindamycin-phosphate
  4. Arava

Clindamycin phosphate and Arava drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Clindamycin phosphate (clindamycin phosphate) and Arava (leflunomide). Common drug interactions include abdominal discomfort among females.

The phase IV clinical study analyzes what interactions people have when they take Clindamycin phosphate and Arava. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Clindamycin phosphate?

Clindamycin phosphate has active ingredients of clindamycin phosphate. It is often used in infection. eHealthMe is studying from 4,216 Clindamycin phosphate users. Check the latest studies of Clindamycin phosphate.

What is Arava?

Arava has active ingredients of leflunomide. It is often used in rheumatoid arthritis. eHealthMe is studying from 76,040 Arava users. Check the latest studies of Arava.

On Jul, 26, 2026

22 people who take Clindamycin phosphate and Arava together, and have interactions are studied.

Clindamycin phosphate and Arava drug interactions.

What are the common drug interactions of Clindamycin Phosphate and Arava, by gender? *:

female:

  1. Abdominal discomfort
  2. Abdominal pain upper
  3. Dyspnoea (difficult or laboured respiration)
  4. Hepatic steatosis (fatty liver disease)
  5. Hypertension (high blood pressure)
  6. Nausea (feeling of having an urge to vomit)
  7. Drug ineffective
  8. Loss of employment
  9. Headache (pain in head)
  10. Drug intolerance (drug sensitivity)

male:

n/a

What are the common drug interactions of Clindamycin Phosphate and Arava, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Abdominal discomfort
  2. Abdominal pain upper
  3. Gastric disorder (disease of stomach)
  4. Arthralgia (joint pain)
  5. Cardiac failure congestive
  6. Cough
  7. Diarrhoea
  8. Drug hypersensitivity
  9. Drug ineffective
  10. Dyspnoea (difficult or laboured respiration)

50-59:

  1. Abdominal discomfort
  2. Hepatic steatosis (fatty liver disease)
  3. Hypertension (high blood pressure)
  4. Malaise (a feeling of general discomfort or uneasiness)
  5. Nausea (feeling of having an urge to vomit)
  6. Rash
  7. Cardiac failure
  8. Drug ineffective
  9. Drug intolerance (drug sensitivity)
  10. Headache (pain in head)

60+:

  1. Drug hypersensitivity

What are the existing conditions these people have? *

  1. Abdominal Discomfort: 5 people, 22.73%
  2. Heart Palpitations (feelings or sensations that your heart is pounding or racing): 3 people, 13.64%
  3. Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Clindamycin phosphate and Arava?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Clindamycin phosphate and Arava:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Clindamycin phosphate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Arava:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Clindamycin phosphate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Arava and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on clindamycin phosphate and leflunomide (the active ingredients of Clindamycin phosphate and Arava, respectively), and Clindamycin phosphate and Arava (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.